Endocrine Society member Will Charton, MD, MAS, has been appointed chief medical office at Spruce Biosciences, Inc., a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. Charlton, a board-certified pediatric endocrinologist with over 15 years of clinical research experience in industry and academia, will […]
